China (Mainland)
Drug peptide Abaloparatide, High purity Peptide cas 247062-33-5 Abaloparatide CAS NO.247062-33-5
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T
- Product Details
Keywords
- BA 058
- BIM 44058
- (Aib29)- Semparatide
Quick Details
- ProName: Drug peptide Abaloparatide, High purit...
- CasNo: 247062-33-5
- Molecular Formula: Alarelin
- Appearance: White Lyophilized powder
- Application: Osteoporosis ，Abaloparatide is an anal...
- DeliveryTime: within 3 days
- PackAge: As client's requirements
- Port: Hangzhou
- ProductionCapacity: 50 Gram/Day
- Purity: 98% Min
- Storage: keep sealed and keep from direct light
- Transportation: Stored in a clean, cool and dry area; ...
- LimitNum: 1 Gram
- Moisture Content: NML 7%
- Impurity: NML1.5%
- application: Osteoporosis
- Active Substance: Abaloparatide is an analog of human pT...
- description: Abaloparatide has shown to induce high...
- sequence: Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-As...
Superiority
Our Advantages:
1.Product Capacity: eptidego has produced thousands of peptides ranging in quantity from milligrams to multiple kilograms with purities up to 99.0%.
2. Samples free trial: our company welcome samples to test our quality then make regular orders.
3. Good Service: the company have 24 hours online service and feedback to our clients ontime
4. Quality guarantee: We have strict quality control system before our delivery and refunds or re-deliver if any quality problems.
5. Fast Delivery and safe shipping: The compnay process orders in time and have much experienced in internation shipping, always keep goods safe shipping and fast delivery.
Details
Name:Abaloparatide
Cas No: 247062-33-5
Formula: C174H300N56O49
Molecular:3960.6
Sequence: Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-Aib-Lys-Leu-His-Thr-Ala-NH2
Function
1.Osteoporosis
Application Research
Abaloparatide has shown to induce higher incidences of osteosarcoma in a dose-dependent manner in a 2 year carcinogenicity study with female and male rats. This correlation is not known to be reflected in humans, however patients with increased risk of osteosarcoma including Paget's disease, open epiphyses, and skeletal malignancies should avoid this treatment. Abaloparatide may also cause hypercalcemia so should be avoided in patients with pre-existing conditions of primary hyperthyroidism or hypercalcemia. Overdose is commonly associated with hypercalcemia, nausea, vomiting, dizziness, tachycardia, orthostatic hypotension and headache. There is no known antidote for abaloparatide.
Specifications
|
Purity (HPLC) |
98% min. |
|
Appearance |
White powder |
|
Single Impurity(HPLC) |
1.0%max |
|
Amino Acid Composition |
±10% of theoretical |
|
Peptide Content(N%) |
≥80.0% |
|
Water Content(Karl Fischer) |
≤8.0% |
|
Acetate Content(HPIC) |
≤12.0% |
|
Specific Rotation (20/D) |
-37.0~-47.0°(c=1 1%HAc) |
|
MS(ESI) |
Consistent |
|
Mass Balance |
95.0~105.0% |
Remarks: The products are restricted in lab research only.
